TURTLE CAMERON (Chief Business Officer) sold 16.0% of their position (12.50K shares) of EIDOS THERAPEUTICS, INC. on the open market
Open‑market sale worth $884.0K — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
Common Stock
Shares
+5K
Price / share
$13.20
Trade value
$66K
% of position
Common Stock
Shares
+2.50K
Price / share
$17.00
Trade value
$42.50K
% of position
Common Stock
Shares
−9.14K
Price / share
$70.44
Trade value
$644.21K
% of position
Common Stock
Shares
−3.15K
Price / share
$71.42
Trade value
$224.68K
% of position
Common Stock
Shares
−209.00
Price / share
$72.10
Trade value
$15.07K
% of position
Net shares
−5K
Net value
-$775.45K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 11/2/2020 | M · Option Exercise | +5K | $13.20 | $66K | 7.1% | 70.53K | 75.53K |
| Common Stock Direct | 11/2/2020 | M · Option Exercise | +2.50K | $17.00 | $42.50K | 3.3% | 75.53K | 78.03K |
| Common Stock Direct | 11/2/2020 | S · Sale | −9.14K | $70.44 | $644.21K | 11.7% | 78.03K | 68.89K |
| Common Stock Direct | 11/2/2020 | S · Sale | −3.15K | $71.42 | $224.68K | 4.6% | 68.89K | 65.74K |
| Common Stock Direct | 11/2/2020 | S · Sale | −209.00 | $72.10 | $15.07K | 0.3% | 65.74K | 65.53K |
| Total | −5K | -$775.45K | ||||||
Stock Option (Right to Buy)
Common Stock
5K shares
Shares
−5K
Strike price
13.20
Held after
75K
Exercisable
—
Stock Option (Right to Buy)
Common Stock
2.50K shares
Shares
−2.50K
Strike price
17.00
Held after
13.92K
Exercisable
—
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock5K shares | 11/2/2020 | M · Option Exercise | −5K | 13.20 | — | 75K |
| Stock Option (Right to Buy) Direct | Common Stock2.50K shares | 11/2/2020 | M · Option Exercise | −2.50K | 17.00 | — | 13.92K |